FDA approves Botox for overactive bladder

By Reuters.com

The popular Botox wrinkle treatment made by Allergan Inc has been approved to treat adults with overactive bladder who cannot tolerate or failed to be helped by other drugs for the condition, the U.S. Food and Drug Administration said on Friday.

Botox injected into the bladder muscle causes the bladder to relax, increasing its storage capacity and reducing episodes of urinary incontinence, or leakage.

"Clinical studies have demonstrated Botox's ability to significantly reduce the frequency of urinary incontinence," Hylton Joffe, director of the FDA's Division of Reproductive and Urologic Products, said in a statement. "Today's approval provides an important additional treatment option for patients with overactive bladder, a condition that affects an estimated 33 million men and women in the United States."

Botox had previously been approved for other non-cosmetic uses, such as migraine headaches, severe underarm sweating and loss of bladder control due to nerve damage.

Allergan, which has yet to report full year financial results, said it expects 2012 Botox sales of $1.76 billion to $1.8 billion. Analysts have said that approval for overactive bladder could add more than $200 million a year to Botox sales.

The treatment can be repeated when the effect wears off, but with a gap of at least 12 weeks between treatments, the FDA said.

About 3.2 million Americans suffering from overactive bladder take oral medications from a class of drugs called anticholinergics, such as Pfizer Inc's Detrol. The Botox approval is for those who are not helped by, or cannot take, those drugs, the FDA said.

Overactive bladder is a condition in which the bladder squeezes too often or squeezes without warning. Symptoms include leaking urine, feeling a sudden and urgent need to urinate, and frequent urination.

Common side effects for Botox injected into the bladder reported during clinical trials included urinary tract infections, painful urination, and incomplete emptying of the bladder, or urinary retention.

People being treated for overactive bladder with Botox should not have a urinary tract infection and should take antibiotics before, during, and for a few days after Botox treatment to lower the chance of developing an infection from the procedure, the FDA said.

Discuss this post

And your bladder will be wrinkle free.

  • 3 votes
Reply#1 - Sat Jan 19, 2013 1:44 PM EST

The article doesn't mention the co$t of a treatment-medically indicated Botox treatments (for muscle contractures, spasticity) aren't cheap, and bladder injections must be a little trickier.

  • 2 votes
Reply#2 - Sat Jan 19, 2013 1:54 PM EST

Just had this done for the FOURTH time! It works great; lasting anywhere from 16-57 months between procedures. Procedure is called CYSTOSCOPY, involves day-surgery. I suppose you could be awake for it, but 20 injections at a time? Thanks, but I'm happier to sleep through it.

  • 2 votes
Reply#3 - Sat Jan 19, 2013 2:47 PM EST

It must be done in conjunctuin with a cystoscopy- cystoscopy is just a scoping of the bladder (like a colonoscopy) But delighted to hear that it worked so well for you, j.sigman. 20 injections does not sound like fun.

    #3.1 - Sat Jan 19, 2013 2:58 PM EST
    Reply

    If a person is subject to getting chronic bladder infections, this procedure does not seem to be feasible.

    • 1 vote
    Reply#4 - Sat Jan 19, 2013 3:00 PM EST

    And just how much of that $200 million a year in Botox sales will go to the ones paid off in the FDA......

    • 1 vote
    Reply#5 - Sat Jan 19, 2013 4:14 PM EST

    FDA approved or not your bladder is not something to fool around with.If drugs like Detrol do not work there are surgeries that can help and then there are always Depends.

    • 1 vote
    Reply#6 - Wed Jan 23, 2013 7:31 PM EST
    You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
    As a new user, you may notice a few temporary content restrictions. Click here for more info.